Compare CLPS & UG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CLPS | UG |
|---|---|---|
| Founded | 2005 | 1942 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Package Goods/Cosmetics |
| Sector | Technology | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.7M | 27.7M |
| IPO Year | 2018 | N/A |
| Metric | CLPS | UG |
|---|---|---|
| Price | $0.93 | $6.14 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 24.0K | 11.6K |
| Earning Date | 10-17-2025 | 11-06-2025 |
| Dividend Yield | ★ 13.85% | 11.29% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.43 |
| Revenue | ★ $164,481,414.00 | $10,060,322.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $14.53 |
| Revenue Growth | ★ 15.17 | N/A |
| 52 Week Low | $0.80 | $5.58 |
| 52 Week High | $1.88 | $11.98 |
| Indicator | CLPS | UG |
|---|---|---|
| Relative Strength Index (RSI) | 53.59 | 57.31 |
| Support Level | $0.92 | $6.08 |
| Resistance Level | $1.01 | $6.21 |
| Average True Range (ATR) | 0.04 | 0.09 |
| MACD | 0.01 | 0.04 |
| Stochastic Oscillator | 57.14 | 100.00 |
CLPS Inc. is an IT consulting and solutions provider serving international clients in the banking, wealth management, e-commerce, and automotive sectors. The company drives digital transformation using AI, cloud computing, and big data, offering IT consulting, customized solutions, virtual banking training, recruitment, professional training, and software services. It operates mainly in two segments: IT services, which generate the majority of its revenue, and academic education services. The company has a presence in Hong Kong, Singapore, Mainland China, India, Malaysia, and Japan, with the majority of its revenue coming from Mainland China.
United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.